Protocatechuic
acid (PCA) is an important drug intermediate with
antibacterial and antioxidant properties. In this study, the whole-cell
bioconversion of l-tyrosine into PCA was explored using artificial
enzymatic cascades engineered in Escherichia coli (E. coli). In particular, the first
biocatalytic route comprises l-amino acid deaminase (LAAD)
from Proteus mirabilis, hydroxymandelate
synthase (HmaS) from Amycolatopsis orientalis, two-component flavin-dependent monooxygenase (HpaBC) from E. coli, hydroxymandelate oxidase (HMO) from Streptomyces coelicolor, benzoylformate decarboxylase
(BFD) from Pseudomonas putida (P. putida), and aldehyde dehydrogenase (ALDH) from Saccharomyces
cerevisiae. Combining LAAD–HmaS–HpaBC
resulted in efficient synthesis of 3,4-dihydroxymandelate (DHMA),
which could be further converted to PCA by HMO–BFD–ALDH
to a final conversion of 64.4%. The second route utilizes 4-hydroxybenzoate
(HBA) hydroxylase (PobA from P. putida) to convert HBA into PCA. As the recombinant E. coli produced >99% conversion of l-tyrosine into HBA within
12 h, further incorporation of PobA resulted in complete conversion
of HBA into PCA, reaching >99% conversion. In summary, the developed
biocatalytic pathway has great potential to produce various high-valued
fine chemicals such as 4-hydroxymandelate (HMA), DHMA, HBA, and PCA.